Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
2.
Transplant Cell Ther ; 27(1): 92.e1-92.e5, 2021 01.
Article in English | MEDLINE | ID: mdl-32961376

ABSTRACT

Although mesenchymal stromal cell (MSC) transfer has long drawn attention owing to its immunosuppressive potential to treat immune-mediated diseases, the role of endogenous MSCs in immune regulation in vivo has remained largely unclear. MSCs constitute the hematopoietic stem cell (HSC) niche, perhaps contributing to immune protection of HSCs, termed immune privilege. Our recent study demonstrates that immune privilege of HSCs is endowed by niche-residential regulatory T cells (Tregs), which promote allogeneic HSC engraftment. This immune privilege depends on cell surface ectoenzymes CD39 and CD73 on niche Tregs, which generate extracellular adenosine, a nucleotide known to suppress immunity and potentiate Tregs. Another niche constituent, leptin receptor-expressing (lepr+) perivascular MSCs, also highly express CD39 and CD73, prompting us to study their roles in immune privilege. This work demonstrates an unexpected negative regulation of immune privilege by MSC-derived adenosine. CD39 deletion in lepr+ cells increased and potentiated effector memory-like niche Tregs, promoting allogeneic HSC engraftment. CD39 deletion in Tregs also activated niche Tregs, while abrogating engraftment. These observations demonstrate paradoxical effects of MSC-derived adenosine to activate immunity, revealing a previously undescribed dual roles of adenosine. Adenosine from both Tregs and MSCs inhibits niche Tregs, whereas adenosine from Tregs, but not that from MSCs, acts as an effector molecule of immune privilege.


Subject(s)
Hematopoietic Stem Cell Transplantation , Mesenchymal Stem Cells , Adenosine , Bone Marrow , Immune Privilege
3.
Haematologica ; 104(6): 1136-1142, 2019 06.
Article in English | MEDLINE | ID: mdl-30545927

ABSTRACT

Various extrinsic signals tightly control hematopoietic stem cell quiescence. Our recent study showed that hematopoietic stem cells are regulated by a special FoxP3+ regulatory T-cell population with high expression of a hematopoietic stem cell marker, CD150. Extracellular adenosine generated via a cell-surface ectoenzyme CD39 on CD150high regulatory T cells maintained hematopoietic stem cell quiescence. It remains unclear how conventional T cells and the other cell-surface ectoenzyme, CD73, contribute to regulation of hematopoietic stem cells. This work shows that CD150high regulatory T cells as well as unique CD150high CD4+ conventional T cells regulate hematopoietic stem cells via CD73. Global CD73 deletion increased the numbers of hematopoietic stem cells, cycling stem cell frequencies, and levels of reactive oxygen species in hematopoietic stem cells. In vivo antioxidant treatment inhibited the increase of hematopoietic stem cells in CD73 knockout mice, suggesting that CD73 maintains stem cell quiescence by preventing oxidative stress. High levels of CD73 expression were frequently found on CD150high regulatory T cells and CD150high FoxP3-CD4+ T cells within the bone marrow. Transfer of these CD150high regulatory T cells and CD150high CD4+ conventional T cells abolished the increase of hematopoietic stem cells in CD73 knockout mice. In addition, the increase of stem cells in CD73 knockout mice was also inhibited by pharmacological activation of adenosine receptor 2A which is highly expressed by hematopoietic stem cells. Taken together, these results suggest that CD73 of CD150high regulatory T cells and CD150high CD4+ conventional T cells protects hematopoietic stem cells from oxidative stress, maintaining stem cell quiescence via adenosine receptor 2A.


Subject(s)
5'-Nucleotidase/metabolism , CD4-Positive T-Lymphocytes/metabolism , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/metabolism , Signaling Lymphocytic Activation Molecule Family Member 1/metabolism , T-Lymphocytes, Regulatory/metabolism , Animals , Biomarkers , CD4-Positive T-Lymphocytes/drug effects , CD4-Positive T-Lymphocytes/immunology , GPI-Linked Proteins/metabolism , Hematopoietic Stem Cells/drug effects , Immunophenotyping , Lymphocyte Activation , Mice , Mice, Knockout , Oxidative Stress , Purinergic P1 Receptor Agonists/pharmacology , T-Lymphocytes, Regulatory/drug effects , T-Lymphocytes, Regulatory/immunology
4.
Cell Stem Cell ; 22(3): 445-453.e5, 2018 03 01.
Article in English | MEDLINE | ID: mdl-29456159

ABSTRACT

A crucial player in immune regulation, FoxP3+ regulatory T cells (Tregs) are drawing attention for their heterogeneity and noncanonical functions. Here, we describe a Treg subpopulation that controls hematopoietic stem cell (HSC) quiescence and engraftment. These Tregs highly expressed an HSC marker, CD150, and localized within the HSC niche in the bone marrow (BM). Specific reduction of BM Tregs achieved by conditional deletion of CXCR4 in Tregs increased HSC numbers in the BM. Adenosine generated via the CD39 cell surface ectoenzyme on niche Tregs protected HSCs from oxidative stress and maintained HSC quiescence. In transplantation settings, niche Tregs prevented allogeneic (allo-) HSC rejection through adenosine and facilitated allo-HSC engraftment. Furthermore, transfer of niche Tregs promoted allo-HSC engraftment to a much greater extent than transfer of other Tregs. These results identify a unique niche-associated Treg subset and adenosine as regulators of HSC quiescence, abundance, and engraftment, further highlighting their therapeutic utility.


Subject(s)
Adenosine/metabolism , Bone Marrow Cells/metabolism , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/immunology , Signaling Lymphocytic Activation Molecule Family Member 1/metabolism , T-Lymphocytes, Regulatory/metabolism , Animals , Mice, Inbred C57BL , Oxidative Stress , Stem Cell Niche
5.
Immunity ; 45(3): 597-609, 2016 09 20.
Article in English | MEDLINE | ID: mdl-27590115

ABSTRACT

Hematopoietic stem cells (HSCs) sustain long-term reconstitution of hematopoiesis in transplantation recipients, yet their role in the endogenous steady-state hematopoiesis remains unclear. In particular, recent studies suggested that HSCs provide a relatively minor contribution to immune cell development in adults. We directed transgene expression in a fraction of HSCs that maintained reconstituting activity during serial transplantations. Inducible genetic labeling showed that transgene-expressing HSCs gave rise to other phenotypic HSCs, confirming their top position in the differentiation hierarchy. The labeled HSCs rapidly contributed to committed progenitors of all lineages and to mature myeloid cells and lymphocytes, but not to B-1a cells or tissue macrophages. Importantly, labeled HSCs gave rise to more than two-thirds of all myeloid cells and platelets in adult mice, and this contribution could be accelerated by an induced interferon response. Thus, classically defined HSCs maintain immune cell development in the steady state and during systemic cytokine responses.


Subject(s)
Cell Lineage/physiology , Hematopoiesis/physiology , Hematopoietic Stem Cells/physiology , Animals , B-Lymphocytes/metabolism , B-Lymphocytes/physiology , Blood Platelets/metabolism , Blood Platelets/physiology , Cell Differentiation/physiology , Hematopoietic Stem Cell Transplantation/methods , Hematopoietic Stem Cells/metabolism , Interferons/metabolism , Macrophages/metabolism , Macrophages/physiology , Mice , Mice, Inbred C57BL , Myeloid Cells/metabolism , Myeloid Cells/physiology
6.
PLoS One ; 10(11): e0141785, 2015.
Article in English | MEDLINE | ID: mdl-26544200

ABSTRACT

NK cells resist engraftment of syngeneic and allogeneic bone marrow (BM) cells lacking major histocompatibility (MHC) class I molecules, suggesting a critical role for donor MHC class I molecules in preventing NK cell attack against donor hematopoietic stem and progenitor cells (HSPCs), and their derivatives. However, using high-resolution in vivo imaging, we demonstrated here that syngeneic MHC class I knockout (KO) donor HSPCs persist with the same survival frequencies as wild-type donor HSPCs. In contrast, syngeneic MHC class I KO differentiated hematopoietic cells and allogeneic MHC class I KO HSPCs were rejected in a manner that was significantly inhibited by NK cell depletion. In vivo time-lapse imaging demonstrated that mice receiving allogeneic MHC class I KO HSPCs showed a significant increase in NK cell motility and proliferation as well as frequencies of NK cell contact with and killing of HSPCs as compared to mice receiving wild-type HSPCs. The data indicate that donor MHC class I molecules are required to prevent NK cell-mediated rejection of syngeneic differentiated cells and allogeneic HSPCs, but not of syngeneic HSPCs.


Subject(s)
Gene Expression Regulation , Hematopoietic Stem Cell Transplantation/adverse effects , Hematopoietic Stem Cells/metabolism , Histocompatibility Antigens Class I/metabolism , Killer Cells, Natural/immunology , Animals , Cell Differentiation , Gene Knockout Techniques , Graft Rejection/immunology , Graft Rejection/prevention & control , Hematopoietic Stem Cells/cytology , Histocompatibility Antigens Class I/genetics , Mice , Molecular Imaging , Transplantation, Homologous/adverse effects , Transplantation, Isogeneic/adverse effects
7.
PLoS One ; 8(8): e69257, 2013.
Article in English | MEDLINE | ID: mdl-23990881

ABSTRACT

We describe a novel photoconversion technique to track individual cells in vivo using a commercial lipophilic membrane dye, DiR. We show that DiR exhibits a permanent fluorescence emission shift (photoconversion) after light exposure and does not reacquire the original color over time. Ratiometric imaging can be used to distinguish photoconverted from non-converted cells with high sensitivity. Combining the use of this photoconvertible dye with intravital microscopy, we tracked the division of individual hematopoietic stem/progenitor cells within the calvarium bone marrow of live mice. We also studied the peripheral differentiation of individual T cells by tracking the gain or loss of FoxP3-GFP expression, a marker of the immune suppressive function of CD4(+) T cells. With the near-infrared photoconvertible membrane dye, the entire visible spectral range is available for simultaneous use with other fluorescent proteins to monitor gene expression or to trace cell lineage commitment in vivo with high spatial and temporal resolution.


Subject(s)
Cell Membrane/metabolism , Coloring Agents/chemistry , Photochemistry , Single-Cell Analysis/methods , Animals , Bone Marrow/metabolism , CD4-Positive T-Lymphocytes/cytology , Cell Differentiation , Cell Lineage , Forkhead Transcription Factors/metabolism , Green Fluorescent Proteins/metabolism , Hematopoietic Stem Cells/cytology , Luminescent Proteins/metabolism , Mice , Mice, Inbred C57BL , Mice, Transgenic , Microscopy, Confocal , Spectrometry, Fluorescence , Staining and Labeling/methods , Stem Cells/cytology , T-Lymphocytes/cytology , Time Factors
8.
Cancer Cell ; 24(1): 45-58, 2013 Jul 08.
Article in English | MEDLINE | ID: mdl-23770013

ABSTRACT

We used an in vivo small hairpin RNA (shRNA) screening approach to identify genes that are essential for MLL-AF9 acute myeloid leukemia (AML). We found that Integrin Beta 3 (Itgb3) is essential for murine leukemia cells in vivo and for human leukemia cells in xenotransplantation studies. In leukemia cells, Itgb3 knockdown impaired homing, downregulated LSC transcriptional programs, and induced differentiation via the intracellular kinase Syk. In contrast, loss of Itgb3 in normal hematopoietic stem and progenitor cells did not affect engraftment, reconstitution, or differentiation. Finally, using an Itgb3 knockout mouse model, we confirmed that Itgb3 is dispensable for normal hematopoiesis but is required for leukemogenesis. Our results establish the significance of the Itgb3 signaling pathway as a potential therapeutic target in AML.


Subject(s)
Integrin beta3/physiology , Leukemia, Myeloid, Acute/etiology , RNA Interference , Signal Transduction/physiology , Animals , Base Sequence , Hematopoietic Stem Cells/physiology , Humans , Integrin beta3/genetics , Leukemia, Myeloid, Acute/pathology , Mice , Mice, Inbred C57BL , Mice, Knockout , Molecular Sequence Data , Myeloid-Lymphoid Leukemia Protein/genetics , Oncogene Proteins, Fusion/genetics , RNA, Small Interfering/genetics , beta Catenin/physiology
9.
Cell Stem Cell ; 10(3): 259-72, 2012 Mar 02.
Article in English | MEDLINE | ID: mdl-22385654

ABSTRACT

Mesenchymal stem cells (MSCs) commonly defined by in vitro functions have entered clinical application despite little definition of their function in residence. Here, we report genetic pulse-chase experiments that define osteoblastic cells as short-lived and nonreplicative, requiring replenishment from bone-marrow-derived, Mx1(+) stromal cells with "MSC" features. These cells respond to tissue stress and migrate to sites of injury, supplying new osteoblasts during fracture healing. Single cell transplantation yielded progeny that both preserve progenitor function and differentiate into osteoblasts, producing new bone. They are capable of local and systemic translocation and serial transplantation. While these cells meet current definitions of MSCs in vitro, they are osteolineage restricted in vivo in growing and adult animals. Therefore, bone-marrow-derived MSCs may be a heterogeneous population with the Mx1(+) population, representing a highly dynamic and stress responsive stem/progenitor cell population of fate-restricted potential that feeds the high cell replacement demands of the adult skeleton.


Subject(s)
Bone Marrow Cells/metabolism , Bone and Bones/metabolism , Fracture Healing , Mesenchymal Stem Cells/metabolism , Animals , Bone Marrow Cells/cytology , Bone and Bones/cytology , Bone and Bones/injuries , Cell Differentiation , Cell Lineage , Cells, Cultured , Humans , Mesenchymal Stem Cells/cytology , Mice , Mice, Inbred C57BL , Osteoblasts/cytology , Stem Cell Transplantation
10.
Nature ; 474(7350): 216-9, 2011 Jun 08.
Article in English | MEDLINE | ID: mdl-21654805

ABSTRACT

Stem cells reside in a specialized regulatory microenvironment or niche, where they receive appropriate support for maintaining self-renewal and multi-lineage differentiation capacity. The niche may also protect stem cells from environmental insults including cytotoxic chemotherapy and perhaps pathogenic immunity. The testis, hair follicle and placenta are all sites of residence for stem cells and are immune-suppressive environments, called immune-privileged sites, where multiple mechanisms cooperate to prevent immune attack, even enabling prolonged survival of foreign allografts without immunosuppression. We sought to determine if somatic stem-cell niches more broadly are immune-privileged sites by examining the haematopoietic stem/progenitor cell (HSPC) niche in the bone marrow, a site where immune reactivity exists. We observed persistence of HSPCs from allogeneic donor mice (allo-HSPCs) in non-irradiated recipient mice for 30 days without immunosuppression with the same survival frequency compared to syngeneic HSPCs. These HSPCs were lost after the depletion of FoxP3 regulatory T (T(reg)) cells. High-resolution in vivo imaging over time demonstrated marked co-localization of HSPCs with T(reg) cells that accumulated on the endosteal surface in the calvarial and trabecular bone marrow. T(reg) cells seem to participate in creating a localized zone where HSPCs reside and where T(reg) cells are necessary for allo-HSPC persistence. In addition to processes supporting stem-cell function, the niche will provide a relative sanctuary from immune attack.


Subject(s)
Graft Survival/immunology , Hematopoietic Stem Cells/immunology , Imaging, Three-Dimensional , Stem Cell Niche/immunology , T-Lymphocytes, Regulatory/immunology , Animals , Cell Survival/immunology , Cells, Cultured , Forkhead Transcription Factors/metabolism , Hematopoietic Stem Cells/cytology , Humans , Interleukin-10/deficiency , Interleukin-10/genetics , Interleukin-10/immunology , Interleukin-10/metabolism , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Stem Cell Niche/cytology , T-Lymphocytes, Regulatory/metabolism , Time Factors , Transplantation, Homologous/immunology
11.
Exp Hematol ; 38(4): 333-9, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20167247

ABSTRACT

OBJECTIVE: In recipients of allogeneic hematopoietic stem cell transplantation to treat hematologic malignancies, we have unexpectedly observed anti-tumor effects in association with donor cell rejection in both mice and humans. Host-type CD8 T cells were shown to be required for these anti-tumor effects in the murine model. Because sustained host CD8 T-cell activation was observed in the murine bone marrow following the disappearance of donor chimerism in the peripheral blood, we hypothesized that donor antigen presentation in the bone marrow might be prolonged. MATERIALS AND METHODS: To assess this hypothesis, we established mixed chimerism with green fluorescent protein (GFP)-positive allogeneic bone marrow cells, induced rejection of the donor cells by giving recipient leukocyte infusions, and utilized in vivo microscopy to follow GFP-positive cells. RESULTS: After peripheral donor leukocytes disappeared, GFP persisted within host myeloid cells surrounding the blood vessels in the bone marrow, suggesting that the host myeloid cells captured donor-derived GFP protein. CONCLUSIONS: Because the host-vs-graft reaction promotes induction of anti-tumor responses in this model, this retention of donor-derived protein may play a role in the efficacy of recipient leukocyte infusions as an anti-tumor therapy.


Subject(s)
Bone Marrow Cells/immunology , CD8-Positive T-Lymphocytes/immunology , Graft Rejection/metabolism , Myeloid Cells/immunology , Animals , Bone Marrow Cells/cytology , Bone Marrow Cells/metabolism , Female , Flow Cytometry , Graft Rejection/chemically induced , Green Fluorescent Proteins/metabolism , Lymphocyte Activation , Mice , Mice, Inbred C57BL , Mice, Transgenic , Transplantation, Homologous
12.
Nature ; 457(7225): 92-6, 2009 Jan 01.
Article in English | MEDLINE | ID: mdl-19052546

ABSTRACT

Stem cells reside in a specialized, regulatory environment termed the niche that dictates how they generate, maintain and repair tissues. We have previously documented that transplanted haematopoietic stem and progenitor cell populations localize to subdomains of bone-marrow microvessels where the chemokine CXCL12 is particularly abundant. Using a combination of high-resolution confocal microscopy and two-photon video imaging of individual haematopoietic cells in the calvarium bone marrow of living mice over time, we examine the relationship of haematopoietic stem and progenitor cells to blood vessels, osteoblasts and endosteal surface as they home and engraft in irradiated and c-Kit-receptor-deficient recipient mice. Osteoblasts were enmeshed in microvessels and relative positioning of stem/progenitor cells within this complex tissue was nonrandom and dynamic. Both cell autonomous and non-autonomous factors influenced primitive cell localization. Different haematopoietic cell subsets localized to distinct locations according to the stage of differentiation. When physiological challenges drove either engraftment or expansion, bone-marrow stem/progenitor cells assumed positions in close proximity to bone and osteoblasts. Our analysis permits observing in real time, at a single cell level, processes that previously have been studied only by their long-term outcome at the organismal level.


Subject(s)
Hematopoietic Stem Cells/cytology , Stem Cell Niche/cytology , Animals , Blood Vessels/cytology , Bone Marrow , Cell Division , Cell Separation , Mice , Mice, Inbred C57BL , Osteoblasts/cytology , Proto-Oncogene Proteins c-kit/genetics , Proto-Oncogene Proteins c-kit/metabolism , Skull/cytology
13.
Circ J ; 69(2): 249-52, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15671623

ABSTRACT

An unusual case of primary cardiac lymphoma presenting as restrictive cardiomyopathy with arrhythmia is reported in a 72-year-old woman who was admitted for evaluation of exertional dyspnea and palpitations. Electrocardiography (ECG) showed atrioventricular dissociation and right heart cardiac catheterization revealed a typical 'dip-and-plateau' waveform. Restrictive cardiomyopathy was suspected because computed tomography (CT) did not reveal pericardial thickening, calcifications, or an effusion. Heart failure initially improved with diuretic therapy, but subsequently worsened, and the patient experienced a syncopal episode. ECG showed atrial fibrillation, and CT revealed a large mass in the right atrium and multiple tumors in the liver, which needle biopsy confirmed as diffuse large B-cell lymphoma. Chemotherapy induced complete remission, and her heart failure markedly improved. The 'dip-and-plateau' waveform was no longer detected on repeat cardiac catheterization and the ECG showed restoration of sinus rhythm. Clinically, the diagnosis was primary cardiac lymphoma.


Subject(s)
Cardiomyopathy, Restrictive/etiology , Heart Neoplasms/diagnosis , Lymphoma, Large B-Cell, Diffuse/diagnosis , Aged , Arrhythmias, Cardiac/etiology , Cardiac Catheterization , Diagnosis, Differential , Electrocardiography , Female , Heart Block , Heart Neoplasms/complications , Humans , Lymphoma, B-Cell/complications , Lymphoma, B-Cell/diagnosis , Lymphoma, Large B-Cell, Diffuse/complications , Remission Induction/methods , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...